يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Lin, Zhong-Zhe"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Current Roles and Future Perspectives of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer.

    المؤلفون: Lin, Zhong-Zhe1,2, Yang, Chih-Hsin2,3,4 chihyang@ntu.edu.tw

    المصدر: European Journal of Clinical & Medical Oncology. 2010, Vol. 2 Issue 3, p1-9. 9p. 2 Charts.

    مصطلحات موضوعية: *LUNG cancer treatment, *PROTEIN-tyrosine kinase inhibitors, *CANCER chemotherapy, *ANTINEOPLASTIC agents, *GENETIC mutation, *EPIDERMAL growth factor receptors, *GENE amplification


    أضف إلى المفضلة
  2. 2
    Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer

    المؤلفون: Shao, Yu-Yun, Shau, Wen-Yi, Lin, Zhong-Zhe, Chen, Ho-Min, Kuo, Raymond, Yang, James Chih-Hsin, Lai, Mei-Shu, 楊志新, 邵幼雲, 賴美淑, 林宗哲

    المساهمون: 臺大公衛學院-流行病學與預防醫學研究所, 臺大醫院-國家級卓越臨床試驗與研究中心, 臺大醫院雲林分院, 臺大醫院-腫瘤醫學部, 臺大醫學院-內科, 臺大醫學院-腫瘤醫學研究所, 臺大醫學院-癌症研究中心

    مصطلحات موضوعية: Comparative effectiveness, Erlotinib, Gefitinib, Non-small-cell lung cancer, Prognosis

    وصف الملف: 108 bytes; text/html

    العلاقة: Eur. J. Cancer, 49(1), 106-114; http://ntur.lib.ntu.edu.tw/handle/246246/259844Test; http://ntur.lib.ntu.edu.tw/bitstream/246246/259844/1/index.htmlTest

    الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/259844Test
    http://ntur.lib.ntu.edu.tw/bitstream/246246/259844/1/index.htmlTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy

    المؤلفون: Perng, Reury-Perng, Yang, Chih-Hsin, Chen, Yuh-Min, Chang, Gee-Chen, Lin, Meng-Chih, Hsieh, Ruey-Kuen, Chu, Nei-Min, Lai, Ruay-Sheng, Su, Wu-Chou, Tsao, Chao-Jung, Hsia, Te-Chun, Chen, Hao-Cheng, Chen, Chih-Hung, Huang, Ming-Shyan, Wang, Jui-Long, Ho, Ming-Lin, Chung, Chih-Yuan, Yu, Chong-Jen, Chang, Wen-Cheng, Kuo, Han-Pin, Yu, Chih-Teng, Lin, Zhong-Zhe, Kao, Woei-Yau

    المساهمون: Department of Internal Medicine

    مصطلحات موضوعية: Carcinoma, Non-small-cell lung, Epidermal growth factor receptor (EGFR), Erlotinib, Asian, Caucasian, Chemotherapy, Tyrosine kinase inhibitor (TKI)

    العلاقة: Lung Cancer, Vol. 62, No. 1, pp. 78-84; http://ir.lib.ncku.edu.tw/handle/987654321/98065Test

    الإتاحة: https://doi.org/10.1016/j.lungcan.2008.02.023Test
    http://ir.lib.ncku.edu.tw/handle/987654321/98065Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients.

    المؤلفون: Yao, Zong-Han1 (AUTHOR) med92leoyau@gmail.com, Liao, Wei-Yu1 (AUTHOR) wyliao33@ntu.edu.tw, Ho, Chao-Chi1 (AUTHOR) ccho1203@ntu.edu.tw, Chen, Kuan-Yu1 (AUTHOR) tuff.chen@msa.hinet.net, Shih, Jin-Yuan1 (AUTHOR) jyshih@ntu.edu.tw, Chen, Jin-Shing2 (AUTHOR) chenjs@ntu.edu.tw, Lin, Zhong-Zhe3 (AUTHOR) zzlin7460@ntu.edu.tw, Lin, Chia-Chi3 (AUTHOR) cclin1@ntu.edu.tw, Yang, James Chih-Hsin3 (AUTHOR) chihyang@ntu.edu.tw, Yu, Chong-Jen1 (AUTHOR) jefferycjyu@ntu.edu.tw

    المصدر: European Journal of Cancer. Aug2019, Vol. 117, p107-115. 9p.

    مصطلحات موضوعية: *LUNG cancer complications, *ANTIGENS, *CONFIDENCE intervals, *DNA, *HEPATITIS B, *HEPATITIS viruses, *LUNG cancer, *PROTEIN-tyrosine kinase inhibitors, *TREATMENT duration, *DESCRIPTIVE statistics, *GEFITINIB, *ERLOTINIB, *DISEASE risk factors


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث